Epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in Southeast Asia

Dermatologica Sinica

Volumn 31, Issue 4, 2013, Pages 217-220

  Lee, Haur Yueh ^a   Martanto, Wijaya ^b   Thirumoorthy, Thamotharampillai ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

epidemiology; southeast Asia; Stevens Johnson syndrome (SJS); toxic epidermal necrolysis (TEN)

Indexed keywords

ALLOPURINOL; CARBAMAZEPINE; LAMOTRIGINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN DERIVATIVE; PHENOBARBITAL; PHENYTOIN; SULFONAMIDE;

ASIAN; DRUG ERUPTION; GEOGRAPHY; HUMAN; INCIDENCE; PHARMACOGENETICS; REVIEW; SOUTHEAST ASIA; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

EID: 84887320669     PISSN: 10278117     EISSN: 2223330X     Source Type: Journal    
DOI: 10.1016/j.dsi.2013.09.007     Document Type: Review

References (44)

1. J.C. Roujeau, J.P. Kelly, and L. Naldi Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis N Engl J Med 333 1995 1600 1607
2. M. Mockenhaupt, C. Viboud, and A. Dunant Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR study J Invest Dermatol 128 2008 35 44
3. J.C. Roujeau, J.C. Guillaume, and J.P. Fabre Toxic epidermal necrolysis (Lyell's syndrome): incidence and drug etiology in France, 1981-1985 Arch Dermatol 126 1990 37 42
4. E. Schopf, A. Stühmer, and B. Rzany Toxic epidermal necrolysis and Stevens syndrome: an epidemiologic study from West Germany Arch Dermatol 127 1991 839 842
5. M. Mockenhaupt Epidemiology of cutaneous adverse drug reactions Chem Immunol Allergy 97 2012 1 17
6. ASEAN Statistics Leaflet: Selected key indicators 2012. Available at: http://www.ASEAN.org [accessed 01.07.13].
7. H.L. Chan Toxic epidermal necrolysis in Singapore 1989 through 1993: incidence and antecedent drug exposure Arch Dermatol 131 1995 1212 1213
8. H.Y. Lee, L.K. Tay, T. Thirumoorthy, and S.M. Pang Cutaneous adverse drug reactions in hospitalised patients Singapore Med J 51 2010 767 774
9. B.Y.H. Thong, K.P. Leong, C.Y. Tang, and H.H. Chng Drug allergy in a general hospital: results of a novel prospective inpatient reporting system Ann Allergy Asthma Immunol 90 2003 342 347
10. S.E. Choon, and N.M. Lai An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia Ind J Derm Venereol Leprol 6 2012 734 739
11. H.L. Chan Observations on drug-induced toxic epidermal necrolysis in Singapore J Am Acad Dermatol 10 1984 973 978
12. W.C. Tan, S.C. Lo Kang, and C.K. Ong Cutaneous adverse drug reactions observed in a dermatology clinic, Penang General Hospital Malays J Derm 21 2008 83 87
13. A.K. Khoo, and C.L. Foo Toxic epidermal necrolysis in a burns centre: a 6-year review Burns 22 1996 275 278
14. E.C. Onishi, and F. Roa Stevens-Johnson syndrome and toxic epidermal necrolysis at the Philippine General Hospital: A seven-year retrospective study J Philipp Dermatol Soc 1 2013 29 36
15. S.K. Tan, and Y.K. Tay Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a General Hospital in Singapore: Treatment outcomes Acta Derm Venereol 92 2012 62 66
16. V. Leenutaphong, A. Sivayathorn, P. Suthipinittharm, and P. Sunthonpalin Stevens-Johnson syndrome and toxic epidermal necrolysis in Thailand Int J Dermatol 32 1993 428 431
17. H.C. Ting, and B.A. Adam Toxic epidermal necrolysis in Malaysian adults: a retrospective study Singapore Med J 26 1985 456 459
18. M.D. Kamaliah, D. Zainal, N. Mokhtar, and N. Nazmi Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in northeast Malaysia Int J Dermatol 37 1998 520 523
19. Lee HY, Thirumoorthy T, Pang SM. Stevens-Johnson syndrome and toxic epidermal necrolysis in Singapore: epidemiology and drug causality. Presented at European Academy of Allergy and Clinical Immunology & World Allergy Organization Meeting, June 22-26, 2013, Milan, Italy.
20. B. Sassolas, C. Haddad, and M. Mockenhaupt ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis Clin Pharmacol Ther 88 2010 60 68
21. Y.C. Giam, S.N. Tham, T. Tan, and A. Lim Drug eruptions from phenylbutazone in Jamu Ann Acad Med Singapore 15 1986 118 121
22. Y.L. Lim, and T. Thirumoorthy Serious cutaneous adverse reactions to traditional Chinese medicines Singapore Med J 46 2005 714 717
23. M. Kamijima, N. Hisanaga, H. Wang, and T. Nakajima Occupational trichloroethylene exposure as a cause of idiosyncratic generalized skin disorders and accompanying hepatitis similar to drug hypersensitivities Int Arch Occup Environ Health 80 2008 357 370
24. W.H. Phoon, M.O. Chan, V.S. Rajan, K.J. Tan, T. Thirumoorthy, and C.L. Goh Stevens-Johnson syndrome associated with occupational exposure to trichloroethylene Contact Dermatitis 10 1984 270 276
25. A.T. Goon, L.T. Lee, Y.K. Tay, G. Yosipovitch, S.K. Ng, and Y.C. Giam A case of trichloroethylene hypersensitivity syndrome Arch Dermatol 137 2001 274 276
26. W.H. Chung, S.I. Hung, and H.S. Hong Medical genetics: a marker for Stevens-Johnson syndrome Nature 428 2004 426
27. S.I. Hung, W.H. Chung, and L.B. Liou HLA-Bâ̂ - 5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol Proc Natl Acad Sci USA 102 2005 4134 4139
28. C. Locharernkul, J. Loplumlert, and C. Limotai Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-Bâ̂ - 1502 allele in Thai population Epilepsia 49 2008 2087 2091
29. W. Tassaneeyakul, S. Tiamkao, and T. Jantararoungtong Association between HLA-Bâ̂ - 1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population Epilepsia 51 2010 926 930
30. C.C. Chang, C.L. Too, S. Murad, and S.H. Hussein Association of HLA-Bâ̂ - 1502 allele with carbamazepine induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population Int J Dermatol 50 2011 221 224
31. S.I. Hung, W.H. Chung, and S.H. Jee Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions Pharmacogenet Genomics 16 2006 297 306
32. C. Lonjou, L. Thomas, and N. Borot A marker for Stevens-Johnson syndrome.: ethnicity matters Pharmacogenomics J 6 2006 265 268
33. W. Tassaneeyakul, T. Jantararoungtong, and P. Chen Strong association between HLA-Bâ̂ - 5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population Pharmacogenet Genomics 19 2009 704 709
34. H.Y. Lee, J.T. Ariyasinghe, and T. Thirumoorthy Allopurinol hypersensitivity syndrome: a preventable severe cutaneous adverse reaction? Singapore Med J 49 2008 384 387
35. S. Athisakul, S. Wangkaew, and W. Louthrenoo Inappropriate prescription of allopurinol in a teaching J Med Assoc Thai 90 2007 889 894
36. A.S. Wu, V.T. Trinh, D. Suki, and S. Graham A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors J Neurosurg 118 2013 873 883
37. P. Chen, J.J. Lin, and C.T. Ong Carbamazepine-induced toxic effects and HLA-Bâ̂ - 1502 screening in Taiwan N Engl J Med 364 2011 1126 1133
38. D. Dong, C. Sung, and E.A. Finkelstein Cost-effectiveness of HLA-Bâ̂ - 1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore Neurology 79 2012 1259 1267
39. J.C. Guillaume, J.C. Roujeau, and J. Revuz The culprit drugs in 87 cases of toxic epidermal necrolysis Arch Dermatol 123 1987 1166 1170
40. S. Halevy, P.D. Ghislain, and M. Mockenhaupt Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel J Am Acad Dermatol 58 2008 25 32
41. M.S. Lin, Y.S. Dai, R.F. Pwu, Y.H. Chen, and N.C. Chang Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study Intern Med J 35 2005 188 190
42. W.Y. Ding, C.K. Lee, and S.E. Choon Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia Int J Dermatol 49 2010 834 841
43. F. Williams, A. Meenagh, and C. Darke Analysis of the distribution of HLA-B alleles in populations from five continents Hum Immunol 62 2001 645 650
44. N. Pimtanothai, P. Charoenwongse, A. Mutirangura, and C.K. Hurley Distribution of HLA-B alleles in nasopharyngeal carcinoma patients and normal controls in Thailand Tissue Antigens 59 2002 223 225